Mannkind Corporation (MNKD) Oversold Based on One Indicator

As the stock of MannKind Corporation (NASDAQ:MNKD) tumbled Wednesday and Thursday, outpacing general stock market declines, while a Forbes report, citing a technical indicator, says it is oversold and might be time for a bounce back. MannKind’s new wonder drug is a dud: Tourbillon MannKind Corporation (NASDAQ:MNKD) had been the subject of short speculation from the hedge fund Tourbillon Capital Partners, first reported by CNBC July 25. Tourbillon had charged that Mannkind’s new wonder drug, considered a cause for the recent dramatic rise in the stock price, is really a dud due to health risks and pricing issues. Mannkind was…